XNYS · Healthcare · Medical Distribution
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q2 2026 | 4.74 | 4.75 | +0.21% | $78.36B | ✅ Beat | +1.01% | +1.16% | — |
| 2026-02-04 | Q1 2026 | 4.05 | 4.08 | +0.74% | $85.93B | ✅ Beat | -0.48% | +10.83% | +8.63% |
| 2025-11-05 |
| Q4 2025 |
| 3.79 |
| 3.84 |
| +1.32% |
| $83.73B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-06 | Q3 2025 | 3.81 | 4.00 | +4.99% | $80.66B | ✅ Beat | — | — | — |
| 2025-02-05 | Q1 2025 | 3.52 | 3.73 | +5.97% | $81.49B | ✅ Beat | -2.82% | -3.83% | +0.51% |
| 2024-11-06 | Q4 2024 | 3.22 | 3.34 | +3.73% | $79.05B | ✅ Beat | +0.97% | +1.87% | -0.80% |
| 2024-07-31 | Q3 2024 | 3.22 | 3.34 | +3.73% | $74.24B | ✅ Beat | +2.77% | +1.35% | +0.71% |
| 2024-05-01 | Q2 2024 | 3.69 | 3.80 | +2.98% | $68.41B | ✅ Beat | -1.95% | -2.22% | -1.15% |
Showing last 8 quarters.